Lady Gaga is now an AI-longevity biotech founder (www.regeneration.ai)

Lady Gaga has co-founded Outer Biosciences, a biotech company focused on longevity, which centers around a novel platform named Yuna. This system utilizes surgically discarded human skin, transforming it into an experimental model for studying responses to various compounds and developing new cosmetic and dermatological ingredients. By combining classical tissue biology with machine learning, Outer aims to create a more robust understanding of how to enhance skin health over time, standing out in a field where many celebrity-backed ventures merely lend their names or invest funds. The significance of Outer Bio lies not only in its innovative approach but also in its capacity to gather extensive data on human skin over a longer duration—up to four weeks—allowing researchers to observe chronic biological processes. This capability could lead to breakthroughs in drug development and cosmetic formulations that are more effective than traditional methods. While other companies have established similar ex vivo skin platforms, Outer aims to differentiate itself by integrating a comprehensive data collection strategy that incorporates histology, protein secretion, and gene expression, potentially reshaping the landscape of the skin longevity market and enhancing collaboration with AI-driven organizations like Haut.AI.